A Mechanistic Study to Evaluate Impact of Afamelanotide in Aqueous Solution on Ultraviolet Radiation-Induced DNA Damage and DNA Repair Capacity in Healthy Volunteers

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505907-21-00

Acronym

CUV158

Enrollment

Registered

2024-02-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Brief summary

The changes in UV photoproducts from pre to post afamelanotide in UVR exposed skin and in non-irradiated skin.

Interventions

DRUGPRENUMBRA

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
The changes in UV photoproducts from pre to post afamelanotide in UVR exposed skin and in non-irradiated skin.	—

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026